Drug Profile
Nicotine replacement therapies - NicoNovum AB
Alternative Names: NN Buccal 104; NN Explorer 203Latest Information Update: 08 Jan 2022
Price :
$50
*
At a glance
- Originator NicoNovum AB
- Class Alkaloids; Analgesics; Drug withdrawal therapies; Nicotine replacement therapy; Pyridines; Small molecules
- Mechanism of Action Nicotinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Smoking withdrawal
Most Recent Events
- 08 Sep 2020 Discontinued - Preclinical for Smoking withdrawal in Sweden (Buccal) (NicoNovum AB pipeline)
- 08 Sep 2020 Discontinued - Preclinical for Smoking withdrawal in Sweden (PO) (NicoNovum AB pipeline)
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Smoking-withdrawal in Sweden (PO, Gum)